KromaTiD Launches dGH™ Cell Prep Kit

LONGMONT, Colo., July 19, 2022 /PRNewswire/ — KromaTiD, a single-cell analysis company focused on the research, development, and commercialization of technology solutions for the cell and gene therapy market, announces the launch of their dGH™ Cell Prep Kit for use in their dGH in-Site™…

Click here to view original post